Status:
COMPLETED
Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Interreg
Conditions:
Preeclampsia
Cardiovascular Risk Factor
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
RATIONALE: Women with a previous history of preeclampsia (PE)/HELLP have a twofold higher risk of cardiovascular disease (CVD) and a fourfold increased risk to develop hypertension at a relative youn...
Eligibility Criteria
Inclusion
- previous preeclampsia/HELLP syndrome, defined as diastolic BP≥90 mmHg with proteinuria ≥ 0.3gram/24 h, during one or more pregnancies, more than 1 year ago.
- 'early' or 'late' PE/HELLP
- age ≥40 and ≤ 60 years
Exclusion
- pregnant women or women wishing for future pregnancie(s)
- inability to perform self BP measurements
- not having a smartphone (Apple or Android)
- already having regular hypertension control by GP or medical specialist
- previous cardiovascular events, such as myocardial infarction , stroke, heart failure and symptomatic ischemic heart disease
Key Trial Info
Start Date :
July 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03228082
Start Date
July 13 2017
End Date
December 30 2019
Last Update
October 6 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholisches Karl-Leisner-Klinikum GmbH
Kleve, Germany
2
Krankenhaus Bethanien
Moers, Germany
3
St. Josef Krankenhaus GmbH
Moers, Germany
4
Rijnstate Ziekenhuis
Arnhem, Netherlands